Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 14, 2020 - Issue 5
Submit an article Journal homepage
2,202
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief

Azfar Athar IshaquiDiscipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia;Department of Pharmacy, King Abdulaziz Hospital, Ministry of National Guard Health – Health Affairs, Alahsa, Saudi Arabia;King Abdullah International Medical Research Center, Alahsa, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-0688-2625View further author information
ORCID Icon,
Amer Hayat KhanDiscipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, MalaysiaCorrespondence[email protected]
View further author information
,
Syed Azhar Syed SulaimanDiscipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, MalaysiaView further author information
,
Muhammad Taher AlsultanDepartment of Pharmacy, King Abdulaziz Hospital, Ministry of National Guard Health – Health Affairs, Alahsa, Saudi Arabia;King Abdullah International Medical Research Center, Alahsa, Saudi ArabiaView further author information
,
Irfanullah KhanDiscipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, MalaysiaView further author information
&
Atta Abbas NaqviDiscipline of Social & Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia;Department of Pharmacy Practice, Imam Abdulrahman Bin Faisal University, Dammam, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-4848-6807View further author information
ORCID Icon
Pages 533-541 | Received 26 Nov 2019, Accepted 12 Feb 2020, Published online: 20 Feb 2020

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Leena Abdulaziz, Esraa Elhadi, Ejlal A Abdallah, Fadlalbaseer A Alnoor & Bashir A Yousef. (2022) Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery. Journal of Experimental Pharmacology 14, pages 97-115.
Read now
Sofía Tejada, Alexandre M. Tejo, Yolanda Peña-López, Carlos G. Forero, Xavier Corbella & Jordi Rello. (2021) Neuraminidase inhibitors and single dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomized controlled trials. Expert Review of Clinical Pharmacology 14:7, pages 901-918.
Read now
Daniel Echeverría-Esnal, Clara Martin-Ontiyuelo, María Eugenia Navarrete-Rouco, Marta De-Antonio Cuscó, Olivia Ferrández, Juan Pablo Horcajada & Santiago Grau. (2021) Azithromycin in the treatment of COVID-19: a review. Expert Review of Anti-infective Therapy 19:2, pages 147-163.
Read now

Articles from other publishers (24)

Evelyn Galindo-Oseguera, Rodolfo Pinto-Almazán, Alfredo Arellano-Ramírez, Gilberto Adrián Gasca-López, María Esther Ocharan-Hernández, Claudia C. Calzada-Mendoza, Juan Castillo-Cruz & Erick Martínez-Herrera. (2023) Mortality and Survival Factors in Patients with Moderate and Severe Pneumonia Due to COVID-19. Healthcare 11:7, pages 932.
Crossref
Ju Hwan Jeong, Santosh Chokkakula, Seong Cheol Min, Beom Kyu Kim, Won-Suk Choi, Sol Oh, Yu Soo Yun, Da Hyeon Kang, Ok-Jun Lee, Eung-Gook Kim, Jang-Hoon Choi, Joo-Yeon Lee, Young Ki Choi, Yun Hee Baek & Min-Suk Song. (2022) Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice. Antiviral Research 208, pages 105430.
Crossref
Georgia G. Kournoutou & George Dinos. (2022) Azithromycin through the Lens of the COVID-19 Treatment. Antibiotics 11:8, pages 1063.
Crossref
Xiao-Guang Li, Jing Chen, Wei Wang, Fei Lin, Lu Li, Jing-Jin Liang, Zhong-Hua Deng, Bi-Ying Zhang, Ying Jia, Yuan-Bo Su, Yong-Feng Kang, Juan Du, Ya-Qiong Liu, Jie Xu & Qing-Bin Lu. (2022) Oseltamivir Treatment for Influenza During the Flu Season of 2018–2019: A Longitudinal Study. Frontiers in Microbiology 13.
Crossref
Abolfazl Zendehdel, Mohammad Bidkhori, Mohsen Ansari, Saeidreza Jamalimoghaddamsiyahkali & Azadeh Asoodeh. (2022) Efficacy of oseltamivir in the treatment of patients infected with Covid-19. Annals of Medicine and Surgery 77, pages 103679.
Crossref
Avishak Sarker, Zichen Gu, Lu Mao, Yongzhuang Ge, Duoduo Hou, Jieyu Fang, Zhanyong Wei & Zhenya Wang. (2022) Influenza-existing drugs and treatment prospects. European Journal of Medicinal Chemistry 232, pages 114189.
Crossref
Saeed Khoshnood, Maryam Shirani, Amine Dalir, Melika Moradi, Mohammad Hossein Haddadi, Nourkhoda Sadeghifard, Faezeh Sabet Birjandi, Ilya Yashmi & Mohsen Heidary. (2022) Antiviral effects of azithromycin: A narrative review. Biomedicine & Pharmacotherapy 147, pages 112682.
Crossref
Marios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, Evangelos Oikonomou, Kostas Tsioufis & Dimitris Tousoulis. (2022) Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?. Biomedicines 10:2, pages 242.
Crossref
DeependraK Rai & PramodK Manjhi. (2022) Mild COVID- 19 Infection: Do we have any Effective Drugs? A Narrative Review. Medical Journal of Dr. D.Y. Patil Vidyapeeth 0:0, pages 0.
Crossref
Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, Matthias M. Engelen, Albrecht Betrains, Quentin Van Thillo, Pham Anh Hong Nguyen, Pieter Goeminne, Ann-Catherine Soenen, Nikolaas De Maeyer, Charles Pilette, Emmanuelle Papleux, Eef Vanderhelst, Aurélie Derweduwen, Patrick Alexander, Bernard Bouckaert, Jean-Benoît Martinot, Lynn Decoster, Kurt Vandeurzen, Rob Schildermans, Peter Verhamme, Wim Janssens & Robin Vos. (2022) Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO). ERJ Open Research 8:1, pages 00610-2021.
Crossref
Saad Alhumaid, Abbas Al Mutair, Zainab Al Alawi, Ahmad J. Alzahrani, Mansour Tobaiqy, Ahmed M. Alresasi, Ibrahim Bu-Shehab, Issa Al-Hadary, Naif Alhmeed, Mossa Alismail, Ahmed H. Aldera, Fadhil AlHbabi, Haifa Al-Shammari, Ali A. Rabaan & Awad Al-Omari. (2021) Antimicrobial susceptibility of gram-positive and gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Joshua Davis, Ugochukwu Umeh & Rand Saba. (2021) Treatment of SARS-CoV-2 (COVID-19): A safety perspective. World Journal of Pharmacology 10:1, pages 1-32.
Crossref
Sabi Ur Rehman, Shaheed Ur Rehman & Hye Hyun Yoo. (2021) COVID-19 challenges and its therapeutics. Biomedicine & Pharmacotherapy 142, pages 112015.
Crossref
Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, S. M. Abdur Rahman & Isa Naina Mohamed. (2021) Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021. Frontiers in Pharmacology 12.
Crossref
Ahmed S. Ali, Mai A. ASattar, Shahid Karim, Dina Kutbi, Hanin Aljohani, Duaa Bakhshwin, Mohammed Alsieni & Huda M. Alkreathy. (2021) Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19. Arabian Journal of Chemistry 14:3, pages 102983.
Crossref
Iwein Gyselinck, Wim Janssens, Peter Verhamme & Robin Vos. (2021) Rationale for azithromycin in COVID-19: an overview of existing evidence. BMJ Open Respiratory Research 8:1, pages e000806.
Crossref
Daniel A. Erku, Sewunet A. Belachew, Solomon Abrha, Mahipal Sinnollareddy, Jackson Thomas, Kathryn J. Steadman & Wubshet H. Tesfaye. (2021) When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19. Research in Social and Administrative Pharmacy 17:1, pages 1954-1963.
Crossref
Abeer A. Tony, Effat AE. Tony, Shazly B. Ali, Azza M. Ezzeldin & Amal A. Mahmoud. (2020) COVID-19-associated sleep disorders: A case report. Neurobiology of Sleep and Circadian Rhythms 9, pages 100057.
Crossref
Kamran Mansouri, Mohsen Rastegari-Pouyani, Maryam Ghanbri-Movahed, Mehrnoush Safarzadeh, Sara Kiani & Zahra Ghanbari-Movahed. (2020) Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational. Biomedicine & Pharmacotherapy 131, pages 110694.
Crossref
Hugo Farne, Kartik Kumar, Andrew I. Ritchie, Lydia J. Finney, Sebastian L. Johnston & Aran Singanayagam. (2020) Repurposing Existing Drugs for the Treatment of COVID-19. Annals of the American Thoracic Society 17:10, pages 1186-1194.
Crossref
John G. Rizk, Kamyar Kalantar-Zadeh, Mandeep R. Mehra, Carl J. Lavie, Youssef Rizk & Donald N. Forthal. (2020) Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs 80:13, pages 1267-1292.
Crossref
Renyi Wu, Lujing Wang, Hsiao-Chen Dina Kuo, Ahmad Shannar, Rebecca Peter, Pochung Jordan Chou, Shanyi Li, Rasika Hudlikar, Xia Liu, Zhigang Liu, George J. Poiani, Louis Amorosa, Luigi Brunetti & Ah-Ng Kong. (2020) An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports 6:3, pages 56-70.
Crossref
Deep Dutta, Meha Sharma & Rahul Sharma. (2020) Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome – Clearing Safety Issues and Good Clinical Practice. European Endocrinology 16:2, pages 109.
Crossref
Dimitri Poddighe & Mohamad Aljofan. (2020) Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond. Antiviral Chemistry and Chemotherapy 28, pages 204020662096171.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.